Kaysia Wilson

Since her regulatory journey began in 2019 Kaysia has worked on a diverse range of over the counter (OTC) and prescription medicines, within different therapeutic areas, in the pharmaceutical industry and in consulting, across Australia and New Zealand.
Kaysia has developed regulatory strategies and has been a project manager for a variety of medicines and clients. Her experience includes submission of new prescription medicines and other complex applications to the Therapeutic Goods Administration (TGA) in Australia.

In addition, Kaysia has broad experience lifecycle management activities including Category 1 and Category 3 variations, labelling reviews and updates, Periodic Safety Update Reports, Risk Management Plan and Australia Specific Annex updates. She has also authored and reviewed Module 1 documents, as well as authored and submitted Changed Medicine Notifications in New Zealand.

Kaysia has managed GMP Clearances for a broad range of global manufacturers. She has also submitted numerous Clinical Trials Notifications and conducted the review of clinical trial labels against the relevant PIC/S annexes.

Having completed the Medicines Australia Program 1 from the University of Tasmania in 2021, Kaysia has the skills and experience to perform regulatory review of promotional materials for healthcare professionals and patients, used in educational and/or public settings.

Kaysia holds a Bachelor of Pharmaceutical Science from Monash University, Australia.